While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them? In this edition of Inside Workers’ Comp, we asked industry experts Chikita Mann, Mark
More stories
Workers' Comp
Article
Turning Regulatory Obstacles into Strategy Advantages Using Informed Decision-Making in Workers’ Comp & Auto Casualty
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in Part 1 of our series, this article explores how advanced bill review technologies can help position payers to effectively navigate current changes and set themselves up for enhanced savings in the long term.
WorkcompWire
Article
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Discover how U.S. trade tariffs and proposed Medicaid cuts could reshape workers’ comp costs and care access. Dave Torrence outlines key risks and strategies in WorkCompWire’s "Leaders Speak" article.
Workers' Comp
Article
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
Discover how vocational case management can reduce claim costs and improve return-to-work outcomes. Essential guide for claims professionals seeking efficient claim resolution.
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp. Discover what this breakthrough could mean for pain management and claims strategies.
Workers' Comp
Article
The Implications of Trump's Health Care Executive Order for Workers' Compensation and Auto Insurers
Explore the immediate effects of President Trump's 2025 health care executive order on workers' compensation and auto insurers, including rising drug costs and supply chain disruptions.
WorkcompWire
In the News
Enlyte Releases 2025 Drug Trends Report, Part 1: Opioids Down, Migraine Meds Up
Enlyte's new Drug Trends Report shows 7.8% drop in opioid use while migraine medications rise 8.7% in workers' comp claims during 2024.